COVID-19: uma abordagem médico-conservacionista

Palavras-chave: Pandemia, SARS-CoV-2, Medicina da Conservação, Impacto Ambiental, Salto Interespecífico

Resumo

Desde o final de 2019, na China, um novo coronavírus passou a provocar síndrome respiratória aguda grave (SARS) que se espalhou pelo mundo e estabeleceu uma pandemia. O surto já acometeu milhões de pessoas, gerou centenas de milhares de mortes e trouxe prejuízo econômico que pode alcançar trilhões de dólares. Vírus como o agente da COVID-19 passam a infectar o homem por episódios de salto da barreira interespecífica, passando por uma ou mais espécies. Assim, a contaminação inicial depende do contato com a vida selvagem, o que se torna cada vez mais comum com a hiperexploração de espécies, a destruição de habitats e o aumento populacional. O estudo desse fluxo de agentes infecciosos, relacionando a medicina humana à sanidade animal e às questões ambientais é  feito pela Medicina da Conservação. A partir de pesquisa exploratória, analisou-se a COVID-19 através da perspectiva médico-conservacionais e mostrou-se que intervenções na origem dos agentes infecciosos seriam capazes de restringir surtos devastadores de doenças e, consequentemente, reduzir impactos sociais e econômicos.

Biografia do Autor

Rodrigo Grazinoli Garrido, UFRJ

Doutor em Ciência pela Universidade Federal Rural do Rio de Janeiro (UFRRJ), Seropédica, RJ, Brasil. Professor Adjunto da Universidade Católica de Petrópolis (UCP/PPGD), RJ, Brasil. Professor Adjunto da Universidade Federal do Rio de Janeiro (UFRJ/FND), RJ, Brasil.

Eduardo Leal Rodrigues, UFSCar

Mestre em Diversidade Biológica e Conservação pela Universidade Federal de São Carlos (UFSCar), Sorocaba, SP, Brasil. Assessor Científico em Identificação Humana da Promega Corporation, São Paulo, SP, Brasil.

 

 

Referências

ALDERS, R. Conservation medicine. Environment Science and Policy for Sustainable Development, [S. l.], v. 51, n. 4, p. 7-8, 2009.

ALEGADO, S. Global cost of coronavirus may reach $ 4.1 trillion, ADBsays. Bloomberg, [S. l.], 2020. Disponível em: https://www.bloomberg.com/news/articles/2020-04-03/global-cost-of-coronavirus-could-reach-4-1-trillion-adb-says. Acesso em: 22 abr. 2020.

ALMEIDA, J. D. et al. Virology: coronavirus. Nature, [S. l.], v. 220, p. 650, 1968.

ANDERSEN, G. A. et al. The proximal origin of SARS-CoV-2. Nature Medicine, [S. l.], v. 26, p. 450-452, 2020. DOI 10.1038/s41591-020-0820-9. Disponível em: https://www.nature.com/articles/s41591-020-0820-9. Acesso em: 1 abr. 2020.

BAKER, Tim; MACDONALD, Laurie. Investing in nature: the economic benefits of conserving natural areas in northeast Florida. Washington: Defenders of Wildlife, 2004. Disponível em: https://defenders.org/sites/default/files/publications/investing_in_nature.pdf. Acesso em: 28 abr. 2020.

BLOOM, D. E.; CARDARETTE, D.; SEVILLA, J. P. The economic risks and impacts of epidemics. F&D Magazine, [S. l.], v. 55, n. 2, p. 46-49, 2018.

BRANN, David H. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. BioRxiv, [S. l.], p. 1-51, 2020. DOI 10.1101/2020.03.25.009084. Disponível em: https://www.biorxiv.org/content/10.1101/2020.03.25.009084v4. Acesso em: 22 abr. 2020.

BRASIL. Lei nº 9.605, de 12 de fevereiro de 1998. Dispõe sobre as sanções penais e administrativas derivadas de condutas e atividades lesivas ao meio ambiente, e dá outras providências. Brasília, DF: Presidência da República, 1998.

BRASIL. Ministério da Saúde. Boletim epidemiológico: identificação de um caso de febre hemorrágica brasileira no estado de São Paulo, Janeiro de 2020. Brasília, DF: Secretaria de Vigilância em Saúde, 2020. Disponível em: http://saude.gov.br/images/pdf/2020/janeiro/20/Boletim-epidemiologico-SVS-03.pdf. Acesso em: 25 abr. 2020.

CAI, J. et al. Indirect virus transmission in cluster of COVID-19 cases, Wenzhou, China, 2020. Emerging Infectious Diseases, [S. l.], v. 26, n. 6, p. 1343-1345, 2020. DOI 10.3201/eid2606.200412. Disponível em: https://wwwnc.cdc.gov/eid/article/26/6/20-0412_article. Acesso em: 22 abr. 2020.

CASADEVALL, A.; PIROFSKI, L. The convalescent sera option for containing COVID-19. The Journal of Clinical Investigation, [S. l.], v. 130, n. 4, p. 1545–1548, 2020. DOI 10.1172/JCI138003. Disponível em: https://www.jci.org/articles/view/138003. Acesso em: 22 abr. 2020.

CHAN, J. F. W. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet, [S. l.], v. 395, p. 514-523, 2020. DOI 10.1016/S0140-6736(20)30154-9. Disponível em: https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)30154-9.pdf. Acesso em: 22 abr. 2020.

CUI, J.; LI, F.; SHI, Z. L. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, [S. l.], v. 17, p. 181–92, 2019.

CUNNINGHAM, A. A.; DASZAK, P.; WOOD, J. L. N. One health, emerging infectious diseases and wildlife: two decades of progress? Philosophical Transactions of the Royal Society B: Biological Sciences, [S. l.], v. 372, n. 1725, 2017. DOI 10.1098/rstb.2016.0167. Disponível em: https://royalsocietypublishing.org/doi/10.1098/rstb.2016.0167. Acesso em: 22 abr. 2020.

DASZAK, P. et al. Conservation medicine and a new agenda for emerging diseases. Annals of the New York Academy of Sciences, [S. l.], v. 1026, p. 1-11, 2004. DOI 10.1196/annals.1307.001. Disponível em: https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1196/annals.1307.001. Acesso em: 22 abr. 2020.

DELIVORIAS, A.; SCHOLZ, N. Economic impact of epidemics and pandemics. [Bruxelas]: EPRS, 2020. Disponível em: https://www.europarl.europa.eu/RegData/etudes/BRIE/2020/646195/EPRS_BRI(2020)646195_EN.pdf. Acesso em: 22 abr. 2020.

DENIS, M.; VANDEWEERD, V.; VAN DER VLIET, D. Overview of information available to support the development of medical countermeasures and interventions against COVID-19. Transdisciplinary Insights - Living Paper, [S. l.], p. 1-120, 2020. Disponível em: https://www.apfh.pt/xfiles/scContentDeployer_pt/links/link92.pdf. Acesso em: 22 abr. 2020.

FAN, V. Y.; JAMISON, D. T.; SUMMERS, L. H. Pandemic risk: how large are the expected losses? Bulletin of the World Health Organization, [S. l.], n. 96, p. 129–134, 2018.

FENG, Z. et al. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19). China CDC Weekly, [S. l.], v. 2, n. 8, p. 113-122, 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32064853/. Acesso em: 22 abr. 2020.

GARRIDO, R. G.; GARRIDO, F. S. R. G. COVID-19: um panorama com ênfase em medidas restritivas de contato interpessoal. Interfaces Científicas - Saúde e Ambiente, [S. l.], v. 8, p. 127-141, 2020.

GE, X. Y. et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature, [S. l.], v. 503, n. 7477, p. 535–538, 2013.

GONZÁLEZ, J.M, et al. A comparative sequence analysis to revise the current taxonomy of the family coronaviridae. Archives of Virology, [S. l.], v. 148, n. 11, p. 2207-2235, 2001.

GORBALENYA, A. E. et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, [S. l.], v. 5, p. 536–544, 2020. DOI 10.1038/s41564-020-0695-z. Disponível em: https://www.nature.com/articles/s41564-020-0695-z. Acesso em: 1 abr. 2020.

GUAN, Y. et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science, [S. l.], v. 302, n. 5643, p. 276-278, 2003. Disponível em: https://science.sciencemag.org/content/302/5643/276. Acesso em: 22 abr. 2020.

INTERNATIONAL COMMITTEE ON TAXONOMY OF VIRUSES. News. [S. l.], 2020. Disponível em: https://talk.ictvonline.org/. Acesso em: 1 abr. 2020.

JONES, K. E. et al. Global trends in emerging infectious diseases. Nature, [S. l.], v. 451, n. 7181, p. 990-993, 2008.

KAKODKAR, P.; KAKA, N.; BAIG, M. N. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus, [S. l.], v. 12, n. 4, p. 1-18, 2020. DOI 10.7759/cureus.7560. Disponível em: https://www.cureus.com/articles/29670-a-comprehensive-literature-review-on-the-clinical-presentation-and-management-of-the-pandemic-coronavirus-disease-2019-covid-19. Acesso em: 22 abr. 2020.

KAMPF, G. et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. The Journal of Hospital Infection, [S. l.], v. 104, n. 3, p. 246-251, 2020. DOI 10.1016/j.jhin.2020.01.022. Disponível em: https://www.journalofhospitalinfection.com/article/S0195-6701(20)30046-3/fulltext. Acesso em: 22 abr. 2020.

KLENK, H. D. et al. Host cell proteases controlling virus pathogenicity. Trends in Microbiology, [S. l.], v. 2, p. 39-43, 1994.

LEE, G. O. M.; WARNER, M. The impact of SARS on China’s human resources: implications for the labour market and level of unemployment in the service sector in Beijing, Guangzhou and Shanghai. The International Journal of Human Resource Management, [S. l.], v. 17, p. 860–880, 2006. DOI 10.1080/09585190600640919. Disponível em: https://www.tandfonline.com/doi/full/10.1080/09585190600640919. Acesso em: 22 abr. 2020.

LI, Q. et al. A simple laboratory parameter facilitates early identification of COVID-19 patients. MedRxiv, [S. l.], p. 1-6, 2020. DOI 10.1101/2020.02.13.20022830. Disponível em: https://www.medrxiv.org/content/10.1101/2020.02.13.20022830v1. Acesso em: 22 abr. 2020.

LI, W. et al. Bats are natural reservoirs of SARS-like coronaviruses. Science, [S. l.], v. 310, n. 5748, p. 676–679, 2005. DOI 10.1126/science.1118391. Disponível em: https://science.sciencemag.org/content/310/5748/676. Acesso em: 22 abr. 2020.

LIU, Y. et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci, [S. l.], v.63, n. 3, p. 364-374, 2020. DOI 10.1007/s11427-020-1643-8. Disponível em: https://link.springer.com/article/10.1007/s11427-020-1643-8. Acesso em: 22 abr. 2020.

LU, H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). BioScience Trends, [S. l.], v. 14, n. 1, p. 69-71, 2020. DOI 10.5582/bst.2020.01020. Disponível em: https://www.jstage.jst.go.jp/article/bst/14/1/14_2020.01020/_article. Acesso em: 22 abr. 2020.

LWCF. Return on the investment from the land and water conservation fund: a report by the trust for public land. Boston: The Trust for Public Land, 2010. Disponível em: http://cloud.tpl.org/pubs/benefits-LWCF-ROI%20Report-11-2010.pdf. Acesso em: 28 abr. 2020.

MCINTOSH, K. Coronaviruses: a comparative review. Current Topics in Microbiology and Immunology, [S. l.], v. 63, p. 85-129, 1974.

NEGRI, E. M. et al. Heparin therapy improving hypoxia in COVID-19 patients - a case series. MedRxiv, [S. l.], p. 1-15, 2020. DOI 2020.04.15.20067017. Disponível em: https://www.medrxiv.org/content/10.1101/2020.04.15.20067017v3. Acesso em: 22 abr. 2020.

NOVEL CORONAVIRUS PNEUMONIA EMERGENCY RESPONSE EPIDEMIOLOGY TEAM. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol, [S. l.], v. 41, n. 2, p. 145-151, 2020.

PIKE, J. et al. Economic optimization of a global strategy to reduce the pandemic threat. PNAS, [S. l.], v. 111, n. 52, p. 18519–18523, 2014. DOI 10.1073/pnas.1412661112. Disponível em: https://www.pnas.org/content/111/52/18519. Acesso em: 22 abr. 2020.

QIU, W. et al. The impacts on health, society, and economy of SARS and H7N9 outbreaks in China: a case comparison study. Journal of Environmental and Public Health, [S. l.], p. 1-8, 2018. DOI 10.1155/2018/2710185. Disponível em: https://www.hindawi.com/journals/jeph/2018/2710185/. Acesso em: 22 abr. 2020.

SANDS, P. et al. Assessment of economic vulnerability to infectious disease crises. The Lancet, [S. l.], v. 388, p. 2443–2448, 2016. DOI 10.1016/S0140-6736(16)30594-3. Disponível em: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30594-3/fulltext. Acesso em: 22 abr. 2020.

SILVEIRA, J. A. G.; D'ELIA, M. L. Medicina da conservação: a ciência da saúde do ecossistema. Cadernos Técnicos de Veterinária e Zootecnia (UFMG), Minas Gerais, v. 72, p. 16-27, 2014.

SMITH, R. D. Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management. Social Science & Medicine, [S. l.], v. 63, n. 12, p. 3113–3123, 2006. DOI 10.1016/j.socscimed.2006.08.004. Disponível em: https://www.sciencedirect.com/science/article/pii/S0277953606004060?via%3Dihub. Acesso em: 1 abr. 2020.

STEINHAUER, D. A. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology, [S. l.], v. 258, p. 1-20, 1999.

TAN, W. et al. Notes from the field: a novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019-2020. China CDC Weekly, [S. l.], v. 2, n. 4, p. 61-62, 2020.

UNDP. A socio-economic impact assessment of the Zika Virus in Latin America and the caribbean: with a focus on Brazil, Colombia and Suriname. New York: UNDP, 2017. Disponível em: https://www.undp.org/content/dam/rblac/docs/Research%20and%20Publications/HIV/UNDP-RBLAC-Zika-English-WEB.pdf. Acesso em: 28 abr. 2020.

VAN DOREMALEN, N. et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, [S. l.], v. 16, n. 382, p. 1564-1567, 2020. DOI 10.1056/NEJMc2004973. Disponível em: https://www.nejm.org/doi/10.1056/NEJMc2004973. Acesso em: 22 abr. 2020.

WALLS, A. C. et al. Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. BioRxiv, [S. l.], p. 1-34, 2020. DOI 10.1101/2020.02.19.956581. Disponível em: https://www.biorxiv.org/content/10.1101/2020.02.19.956581v1. Acesso em: 1 abr. 2020.

WAN, Y. et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. Journal of Virology, [S. l.], v. 94, n. 7, 2020. DOI 10.1128/JVI.00127-20. Disponível em: https://jvi.asm.org/content/94/7/e00127-20. Acesso em: 1 abr. 2020.

WANG, N. et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Research, [S. l.], v. 23, n. 8, p. 986-93, 2013. DOI 10.1038/cr.2013.92. Disponível em: https://www.nature.com/articles/cr201392. Acesso em: 1 abr. 2020.

WEISS, S. R.; NAVAS-MARTIN, S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiology and Molecular Biology Reviews, [S. l.], v. 9, n. 4, p. 635–664, 2005.

WHO. Coronavirus disease (COVID-19): situation report – 122. [Genebra]: WHO, 2020a. Disponível em: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200521-covid-19-sitrep-122.pdf?sfvrsn=24f20e05_2. Acesso em: 22 maio 2020.

WHO. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva: WHO, 2020b. Disponível em: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). Acesso em: 25 mar. 2020.

WHO. DRAFT landscape of COVID-19 candidate vaccines – 20 April 2020. [Genebra]: WHO, 2020c. Disponível em: https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1. Acesso em: 25 mar. 2020.

WORLD BANK GROUP. Pandemic emergency financing facility. [S. l.], 2019. Disponível em: https://www.worldbank.org/en/topic/pandemics/brief/pandemic-emergency-financing-facility?cid=EXT_WBSocialShare_EXT. Acesso em: 25 abr. 2020.

WRAPP, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, [S. l.], v. 367, n. 6483, p. 1260-1263, 2020.

WU, Y. et al. SARS-CoV-2 is an appropriate name for the new coronavirus. The Lancet, [S. l.], v. 395, n. 10228, p. 949-950, 2020. Disponível em: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30557-2/fulltext. Acesso em: 22 abr. 2020.

YAO, H. et al. Patient-derived mutations impact pathogenicity of SARS-CoV-2. MedRxiv, [S. l.], p. 1-57, 2020. DOI 10.1101/2020.04.14.20060160. Disponível em: https://www.medrxiv.org/content/10.1101/2020.04.14.20060160v2. Acesso em: 22 abr. 2020.

ZHOU, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, [S. l.], v. 579, p. 270–273, 2020.
Publicado
2020-06-03